Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PTC Therapeutics (PTCT)
NASDAQ:PTCT
Holding PTCT?
Track your performance easily
See the Price Targets and Ratings of:
PTCT Analyst Ratings
Moderate Buy
7 Buy
4 Hold
3 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PTCT Stock 12 Month Forecast
Average Price Target
$55.67
▲(14.52% Upside)
| Highest Price Target$71.00 | Average Price Target$55.67 | Lowest Price Target$32.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Upgraded
12/13/24
RBC Capital
Reiterated
12/13/24
Robert W. Baird
Reiterated
12/03/24
Goldman Sachs
Reiterated
12/03/24
Barclays
Reiterated
12/03/24
Leerink Partners
Reiterated
12/02/24
William Blair
Reiterated
12/02/24
J.P. Morgan
Reiterated
12/02/24
Bank of America Securities
$31→$41
Sell
-15.66%
Downside
Reiterated
12/02/24
Cautious Outlook on PTC Therapeutics Amid Regulatory Uncertainties and Clinical Data Gaps
Wells Fargo
$68
Buy
39.89%
Upside
Assigned
12/02/24
PTC Therapeutics' Strategic Deal and Strong Financial Position Justify Buy Rating
TD Cowen
$38→$46
Hold
-5.37%
Downside
Reiterated
12/02/24
Hold Recommendation for PTC Therapeutics: Balancing Promising Prospects with Regulatory and Competitive Challenges
Raymond James
―
Hold
―
Initiated
10/10/24
Raymond James resumes PTC Therapeutics (PTCT) at Market PerformRaymond James analyst Danielle Brill resumes coverage on PTC Therapeutics (NASDAQ: PTCT) with a Market Perform rating.
Cantor Fitzgerald
$64
Buy
31.66%
Upside
Reiterated
09/16/24
Cantor Fitzgerald Sticks to Its Buy Rating for PTC Therapeutics (PTCT)
Best Analysts Covering PTC Therapeutics
Which Analyst Should I Follow If I Want to Buy PTCT and Sell After:
1 Month
xxx
Success Rate
12/17 ratings generated profit
Average Return
+4.49%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.59% of your transactions generating a profit, with an average return of +4.49% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+6.37%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +6.37% per trade.
1 Year
Success Rate
14/17 ratings generated profit
Average Return
+32.78%
reiterated a buy rating 22 days ago
Copying Joel Beatty's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +32.78% per trade.
2 Years
xxx
Success Rate
14/15 ratings generated profit
Average Return
+40.35%
reiterated a xxx
rating 23 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 93.33% of your transactions generating a profit, with an average return of +40.35% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PTCT Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
7
5
4
2
1
Buy
7
4
7
11
17
Hold
10
9
14
18
21
Sell
7
2
5
5
8
Strong Sell
0
0
0
0
0
total
31
20
30
36
47
Each month's total comprises the sum of three months' worth of ratings.
PTCT Financial Forecast
PTCT Stock Forecast FAQ
What is PTCT’s average 12-month price target, according to analysts?
Based on analyst ratings, PTC Therapeutics’s 12-month average price target is $55.67.
What is PTCT’s upside potential, based on the analysts’ average price target?
PTC Therapeutics has 14.52% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PTCT a Buy, Sell or Hold?
PTC Therapeutics has a consensus rating of Moderate Buy which is based on 7 buy ratings, 4 hold ratings and 3 sell ratings.
What is PTC Therapeutics’s price target?
The average price target for PTC Therapeutics is $55.67. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $71.00 ,the lowest forecast is $32.00. The average price target represents 14.52% Increase from the current price of $48.61.
The highest analyst price target is $71.00 ,the lowest forecast is $32.00. The average price target represents 14.52% Increase from the current price of $48.61.
What do analysts say about PTC Therapeutics?
PTC Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of PTCT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.